362 related articles for article (PubMed ID: 31336112)
1. Evaluation of the Wistar-Kyoto rat model of depression and the role of synaptic plasticity in depression and antidepressant response.
Aleksandrova LR; Wang YT; Phillips AG
Neurosci Biobehav Rev; 2019 Oct; 105():1-23. PubMed ID: 31336112
[TBL] [Abstract][Full Text] [Related]
2. Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression.
Aleksandrova LR; Wang YT; Phillips AG
Mol Brain; 2020 Jun; 13(1):92. PubMed ID: 32546197
[TBL] [Abstract][Full Text] [Related]
3. Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat.
Sairanen M; O'Leary OF; Knuuttila JE; Castrén E
Neuroscience; 2007 Jan; 144(1):368-74. PubMed ID: 17049169
[TBL] [Abstract][Full Text] [Related]
4. The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex.
Liu W; Ge T; Leng Y; Pan Z; Fan J; Yang W; Cui R
Neural Plast; 2017; 2017():6871089. PubMed ID: 28246558
[TBL] [Abstract][Full Text] [Related]
5. Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression.
Willner P; Gruca P; Lason M; Tota-Glowczyk K; Litwa E; Niemczyk M; Papp M
Behav Pharmacol; 2019 Apr; 30(2 and 3-Spec Issue):239-250. PubMed ID: 30204592
[TBL] [Abstract][Full Text] [Related]
6. Genomic Screening of Wistar and Wistar-Kyoto Rats Exposed to Chronic Mild Stress and Deep Brain Stimulation of Prefrontal Cortex.
Papp M; Gruca P; Faron-Górecka A; Kusmider M; Willner P
Neuroscience; 2019 Dec; 423():66-75. PubMed ID: 31705885
[TBL] [Abstract][Full Text] [Related]
7. Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit.
Yao N; Skiteva O; Zhang X; Svenningsson P; Chergui K
Mol Psychiatry; 2018 Oct; 23(10):2066-2077. PubMed ID: 29158578
[TBL] [Abstract][Full Text] [Related]
8. Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways.
Kim JW; Monteggia LM
Behav Brain Res; 2020 Feb; 380():112378. PubMed ID: 31760154
[TBL] [Abstract][Full Text] [Related]
9. S-Ketamine Exerts Antidepressant Effects by Regulating Rac1 GTPase Mediated Synaptic Plasticity in the Hippocampus of Stressed Rats.
Zhu X; Zhang F; You Y; Wang H; Yuan S; Wu B; Zhu R; Liu D; Yan F; Wang Z
Cell Mol Neurobiol; 2023 Jan; 43(1):299-314. PubMed ID: 35083636
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway.
Jett JD; Boley AM; Girotti M; Shah A; Lodge DJ; Morilak DA
Psychopharmacology (Berl); 2015 Sep; 232(17):3123-33. PubMed ID: 25986748
[TBL] [Abstract][Full Text] [Related]
11. Ketamine facilitates extinction of avoidance behavior and enhances synaptic plasticity in a rat model of anxiety vulnerability: Implications for the pathophysiology and treatment of anxiety disorders.
Fortress AM; Smith IM; Pang KCH
Neuropharmacology; 2018 Jul; 137():372-381. PubMed ID: 29750979
[TBL] [Abstract][Full Text] [Related]
12. The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus.
Burgdorf J; Zhang XL; Weiss C; Gross A; Boikess SR; Kroes RA; Khan MA; Burch RM; Rex CS; Disterhoft JF; Stanton PK; Moskal JR
Neuroscience; 2015 Nov; 308():202-11. PubMed ID: 26343295
[TBL] [Abstract][Full Text] [Related]
13. Brain structure and synaptic protein expression alterations after antidepressant treatment in a Wistar-Kyoto rat model of depression.
Li Q; Gao Y; Li H; Liu H; Wang D; Pan W; Liu S; Xu Y
J Affect Disord; 2022 Oct; 314():293-302. PubMed ID: 35878834
[TBL] [Abstract][Full Text] [Related]
14. Possible antidepressant effects and mechanisms of memantine in behaviors and synaptic plasticity of a depression rat model.
Quan MN; Zhang N; Wang YY; Zhang T; Yang Z
Neuroscience; 2011 May; 182():88-97. PubMed ID: 21440043
[TBL] [Abstract][Full Text] [Related]
15. Neurovascular plasticity of the hippocampus one week after a single dose of ketamine in genetic rat model of depression.
Ardalan M; Wegener G; Polsinelli B; Madsen TM; Nyengaard JR
Hippocampus; 2016 Nov; 26(11):1414-1423. PubMed ID: 27440163
[TBL] [Abstract][Full Text] [Related]
16. Restoring mood balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticity.
Belujon P; Grace AA
Biol Psychiatry; 2014 Dec; 76(12):927-36. PubMed ID: 24931705
[TBL] [Abstract][Full Text] [Related]
17. Single and chronic L-serine treatments exert antidepressant-like effects in rats possibly by different means.
Nagasawa M; Otsuka T; Togo Y; Yamanaga M; Yoshida J; Uotsu N; Teramoto S; Yasuo S; Furuse M
Amino Acids; 2017 Sep; 49(9):1561-1570. PubMed ID: 28589394
[TBL] [Abstract][Full Text] [Related]
18. Differences between ketamine's short-term and long-term effects on brain circuitry in depression.
Gass N; Becker R; Reinwald J; Cosa-Linan A; Sack M; Weber-Fahr W; Vollmayr B; Sartorius A
Transl Psychiatry; 2019 Jun; 9(1):172. PubMed ID: 31253763
[TBL] [Abstract][Full Text] [Related]
19. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.
Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM
Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase Mζ in medial prefrontal cortex mediates depressive-like behavior and antidepressant response.
Yan W; Liu JF; Han Y; Zhang W; Luo YX; Xue YX; Zhu WL; Yang C; Chen WH; Guo HL; Ma YN; Yuan K; Wang JS; Shi J; Lu L
Mol Psychiatry; 2018 Sep; 23(9):1878-1891. PubMed ID: 29180675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
